{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:31:44Z","timestamp":1777044704801,"version":"3.51.4"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Humans interact with a multitude of microorganisms in various ecological relationships, ranging from commensalism to pathogenicity. The same applies to fungi, long recognized for their pathogenic roles in infection\u2013such as in invasive fungal diseases caused, among others, by <jats:italic>Aspergillus fumigatus<\/jats:italic> and <jats:italic>Candida<\/jats:italic> spp.\u2013and, more recently, for their beneficial activities as an integral part of the microbiota. Indeed, alterations in the fungal component of the microbiota, or mycobiota, have been associated with inflammatory, infectious and metabolic diseases, and cancer. Whether acting as opportunistic pathogens or symbiotic commensals, fungi possess a complex enzymatic repertoire that intertwines with that of the host. In this metabolic cross-talk, fungal enzymes may be unique, thus providing novel metabolic opportunities to the host, or, conversely, produce toxic metabolites. Indeed, administration of fungal probiotics and fungi-derived products may be beneficial in inflammatory and infectious diseases, but fungi may also produce a plethora of toxic secondary metabolites, collectively known as mycotoxins. Fungal enzymes may also be homologues to human enzymes, but nevertheless embedded in fungal-specific metabolic networks, determined by all the interconnected enzymes and molecules, quantitatively and qualitatively specific to the network, such that the activity and metabolic effects of each enzyme remain unique to fungi. In this Opinion, we explore the concept that targeting this fungal metabolic unicity, either in opportunistic pathogens or commensals, may be exploited to develop novel therapeutic strategies. In doing so, we present our recent experience in different pathological settings that ultimately converge on relevant trans-kingdom metabolic differences.<\/jats:p>","DOI":"10.3389\/fmolb.2024.1386598","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T04:18:55Z","timestamp":1713932335000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Harnessing inter-kingdom metabolic disparities at the human-fungal interface for novel therapeutic approaches"],"prefix":"10.3389","volume":"11","author":[{"given":"Claudio","family":"Costantini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilena","family":"Pariano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Puccetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Giovagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioena","family":"Pampalone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirco","family":"Dindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Cellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigina","family":"Romani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e155860","DOI":"10.1172\/JCI155860","article-title":"Indoxyl sulfate in uremia: an old idea with updated concepts","volume":"132","author":"Berg","year":"2022","journal-title":"J. Clin. Invest."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.4049\/jimmunol.174.5.2910","article-title":"A crucial role for tryptophan catabolism at the host\/Candida albicans interface","volume":"174","author":"Bozza","year":"2005","journal-title":"J. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.mib.2009.05.004","article-title":"Fungal metabolism in host niches","volume":"12","author":"Brock","year":"2009","journal-title":"Curr. Opin. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"22692","DOI":"10.1038\/s41598-023-50121-4","article-title":"Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study","volume":"13","author":"Cellini","year":"2023","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3389\/fimmu.2017.01996","article-title":"A multifaceted role of tryptophan metabolism and indoleamine 2,3-dioxygenase activity in Aspergillus fumigatus-host interactions","volume":"8","author":"Choera","year":"2017","journal-title":"Front. Immunol."},{"key":"B7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-12-822564-6.00008-2","article-title":"Chapter 15 - the immune system and the microbiota: the two sides of mucosal tolerance","volume-title":"Translational autoimmunity","author":"Costantini","year":"2022"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e230020","DOI":"10.1530\/mah-23-0020","article-title":"Commensal fungi and oxalate degradation: is there a link?","volume":"2","author":"Costantini","year":"2024","journal-title":"Microbiota Host"},{"key":"B9","doi-asserted-by":"publisher","first-page":"112717","DOI":"10.1016\/j.ejmech.2020.112717","article-title":"Selectively targeting key inflammatory pathways in cystic fibrosis","volume":"206","author":"Costantini","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/gm467","article-title":"The human mycobiome in health and disease","volume":"5","author":"Cui","year":"2013","journal-title":"Genome Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0054421","DOI":"10.1128\/AEM.00544-21","article-title":"Forty years of oxalobacter formigenes, a gutsy oxalate-degrading specialist","volume":"87","author":"Daniel","year":"2021","journal-title":"Appl. Environ. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"W510","DOI":"10.1093\/nar\/gky299","article-title":"iPath3.0: interactive pathways explorer v3","volume":"46","author":"Darzi","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00240-018-1089-z","article-title":"Molecular basis of primary hyperoxaluria: clues to innovative treatments","volume":"47","author":"Dindo","year":"2019","journal-title":"Urolithiasis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"107746","DOI":"10.1016\/j.pharmthera.2020.107746","article-title":"Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets","volume":"221","author":"Dolsak","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41581-022-00643-3","article-title":"Oxalate homeostasis","volume":"19","author":"Ermer","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.febslet.2013.11.026","article-title":"An oxalyl-CoA synthetase is important for oxalate metabolism in Saccharomyces cerevisiae","volume":"588","author":"Foster","year":"2014","journal-title":"FEBS Lett."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"40406","DOI":"10.1038\/srep40406","article-title":"Targeting pathogen metabolism without collateral damage to the host","volume":"7","author":"Haanstra","year":"2017","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/21505594.2016.1247140","article-title":"Fungi in the healthy human gastrointestinal tract","volume":"8","author":"Hallen-Adams","year":"2017","journal-title":"Virulence"},{"key":"B20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21037\/atm.2016.12.70","article-title":"Gut microbiota and oxalate homeostasis","volume":"5","author":"Hatch","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/genetics\/156.4.1519","article-title":"Accumulation of phosphorylated sphingoid long chain bases results in cell growth inhibition in Saccharomyces cerevisiae","volume":"156","author":"Kim","year":"2000","journal-title":"Genetics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"9487","DOI":"10.3390\/ijms22179487","article-title":"The multifaceted role of serotonin in intestinal homeostasis","volume":"22","author":"Koopman","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"102122","DOI":"10.1016\/j.jbc.2022.102122","article-title":"Evolutionary origin and functional diversification of aminotransferases","volume":"298","author":"Koper","year":"2022","journal-title":"J. Biol. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e63642","DOI":"10.7554\/eLife.63642","article-title":"Microbial genetic and transcriptional contributions to oxalate degradation by the gut microbiota in health and disease","volume":"10","author":"Liu","year":"2021","journal-title":"Elife"},{"key":"B25","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.tem.2020.02.012","article-title":"Gut microbial metabolites of aromatic amino acids as signals in host-microbe interplay","volume":"31","author":"Liu","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1471-4159.2004.02850.x","article-title":"Different properties of the central and peripheral forms of human tryptophan hydroxylase","volume":"92","author":"McKinney","year":"2005","journal-title":"J. Neurochem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/s41559-023-02095-9","article-title":"Genomes of fungi and relatives reveal delayed loss of ancestral gene families and evolution of key fungal traits","volume":"7","author":"Merenyi","year":"2023","journal-title":"Nat. Ecol. Evol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e00088","DOI":"10.1128\/mSystems.00088-17","article-title":"The induction of oxalate metabolism in vivo is more effective with functional microbial communities than with functional microbial species","volume":"2","author":"Miller","year":"2017","journal-title":"mSystems"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1038\/s41467-023-39982-5","article-title":"Genome-scale metabolic modeling of Aspergillus fumigatus strains reveals growth dependencies on the lung microbiome","volume":"14","author":"Mirhakkak","year":"2023","journal-title":"Nat. Commun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12575-015-0020-z","article-title":"The diversity of fungal genome","volume":"17","author":"Mohanta","year":"2015","journal-title":"Biol. Proced. Online"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.FUNK-0036-2016","article-title":"Six key traits of fungi: their evolutionary origins and genetic bases","volume":"5","author":"Nagy","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s13225-023-00520-9","article-title":"The contribution of fungi to the global economy","volume":"121","author":"Niego","year":"2023","journal-title":"Fungal Divers."},{"key":"B33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/pharmaceutics15020506","article-title":"Turning microbial AhR agonists into therapeutic agents via drug delivery systems","volume":"15","author":"Puccetti","year":"2023","journal-title":"Pharmaceutics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.1038\/s41467-023-41536-8","article-title":"Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia","volume":"14","author":"Renga","year":"2023","journal-title":"Nat. Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0011136","DOI":"10.1371\/journal.pntd.0011136","article-title":"Recognition of fungal priority pathogens: what next?","volume":"17","author":"Rodrigues","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.4155\/fmc-2016-0053","article-title":"Sphingolipids as targets for treatment of fungal infections","volume":"8","author":"Rollin-Pinheiro","year":"2016","journal-title":"Future Med. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nri2939","article-title":"Immunity to fungal infections","volume":"11","author":"Romani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1186\/gb-2004-6-1-r2","article-title":"Computational prediction of human metabolic pathways from the complete human genome","volume":"6","author":"Romero","year":"2005","journal-title":"Genome Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/9781118958308.ch18","article-title":"Fungal metabolic diversity","author":"Steindorff","year":"2015","journal-title":"Fungal Biomol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s40265-023-01976-4","article-title":"Nedosiran: first approval","volume":"83","author":"Syed","year":"2023","journal-title":"Drugs"},{"key":"B41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/s1369-5274(02)00355-7","article-title":"Genomics of parasitic and symbiotic fungi","volume":"5","author":"Tunlid","year":"2002","journal-title":"Curr. Opin. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro.2017.90","article-title":"Aspergillus fumigatus morphology and dynamic host interactions","volume":"15","author":"van de Veerdonk","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"L1000","DOI":"10.1152\/ajplung.00298.2016","article-title":"Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931","volume":"311","author":"Veltman","year":"2016","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1126\/science.1078197","article-title":"Synthesis of serotonin by a second tryptophan hydroxylase isoform","volume":"299","author":"Walther","year":"2003","journal-title":"Science."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1004816","DOI":"10.1371\/journal.pgen.1004816","article-title":"The evolution of fungal metabolic pathways","volume":"10","author":"Wisecaver","year":"2014","journal-title":"PLoS Genet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00239-010-9412-5","article-title":"Molecular evolution and characterization of fungal indoleamine 2,3-dioxygenases","volume":"72","author":"Yuasa","year":"2011","journal-title":"J. Mol. Evol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.gene.2012.04.082","article-title":"The evolution of three types of indoleamine 2,3 dioxygenases in fungi with distinct molecular and biochemical characteristics","volume":"504","author":"Yuasa","year":"2012","journal-title":"Gene"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/jez.b.22608","article-title":"Efficient tryptophan-catabolizing activity is consistently conserved through evolution of TDO enzymes, but not Ido enzymes","volume":"324","author":"Yuasa","year":"2015","journal-title":"J. Exp. Zool. B Mol. Dev. Evol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.gene.2011.06.002","article-title":"Molecular evolution of bacterial indoleamine 2,3-dioxygenase","volume":"485","author":"Yuasa","year":"2011","journal-title":"Gene"},{"key":"B50","doi-asserted-by":"publisher","first-page":"108673","DOI":"10.1016\/j.celrep.2020.108673","article-title":"Aspergillus fumigatus tryptophan metabolic route differently affects host immunity","volume":"34","author":"Zelante","year":"","journal-title":"Cell Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"key":"B52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coi.2020.12.004","article-title":"Regulation of host physiology and immunity by microbial indole-3-aldehyde","volume":"70","author":"Zelante","year":"","journal-title":"Curr. Opin. Immunol."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2024.1386598\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T04:19:09Z","timestamp":1713932349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2024.1386598\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":53,"alternative-id":["10.3389\/fmolb.2024.1386598"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2024.1386598","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"article-number":"1386598"}}